Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: Curcumol inhibits breast cancer growth via NCL/ERα36 and the PI3K/AKT pathway
Lu Wei
Zhou
a,
Juan
Wang
abcde,
Tong
Dou
af,
Xiao Juan
Li
a,
Yi Sa
Liu
a,
Meng Jie
Huang Fu
a,
Xiao
Guan
a,
Guo Xiang
Liu
a,
Meng Jie
Han
a and
Xu
Chen
*a
aDepartment of Pharmacy, Guilin Medical University, Guilin 541199, P. R. China. E-mail: chenxu@glmc.edu.cn; Fax: +86-773-5898018; Tel: +86-773-5898018
bKey Laboratory of Pharmacognosy, Education Department of Guangxi Zhuang Autonomous Region, 541199, P. R. China
cGuangxi Key Laboratory of Molecular Medicine in Liver Injury and Repair, Guilin Medical University, 541001, P. R. China
dGuangxi Health Commission Key Laboratory of Basic Research in Sphingolipid Metabolism Related Diseases, the Affiliated Hospital of Guilin Medical University, Guilin, 541001, Guangxi, China
eFaculty of Basic Medicine, Guilin Medical University, No. 109, Guilin 541004, P. R. China
fSchool of Pharmacy, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau, China
First published on 19th January 2023
Abstract
Correction for ‘Curcumol inhibits breast cancer growth via NCL/ERα36 and the PI3K/AKT pathway’ by Zhou Lu Wei et al., Food Funct., 2023, https://doi.org/10.1039/d2fo02387c.
The authors regret that Zhou Lu Wei was incorrectly listed as being affiliated with the Faculty of Basic Medicine, Guilin Medical University. The correct affiliations list is shown here.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2023 |